Competition Law Update: SAMR Issues New Guidance on IP-Related Antitrust Cases — Key Takeaways

On December 15, 2024, China’s State Administration for Market Regulation (国家市场监督管理总局, SAMR, guójiā shìchǎng jiāndū guǎnlǐ zǒngjú) released Version 2.0 of the Anti-Monopoly Compliance Guidelines for Intellectual Property Rights (知识产权反垄断合规指南, zhīshì chǎnquán fǎnlǒngduàn héguī zhǐnán) — a 68-page document that consolidates 12 precedent-setting cases and introduces 23 specific compliance indicators for companies licensing, transferring, or enforcing IP rights in China. This is the first major revision since the original 2019 framework, signaling Beijing’s intent to sharpen antitrust scrutiny of patent pools, standard-essential patents (SEPs), and licensing practices across technology, pharmaceuticals, and manufacturing sectors.

The updated guidance arrives against a backdrop of rising antitrust enforcement in China: SAMR handled 38 IP-related antitrust investigations between 2020 and 2024, a 2.5× increase compared to the 2015-2019 period. By comparison, the European Commission handles roughly 8-10 similar cases annually, and the U.S. DOJ averages 5-7 — making China the most active jurisdiction globally for IP antitrust enforcement. Foreign companies that hold patents, copyrights, or trade secrets in China must now recalibrate their compliance programs to avoid fines that can reach up to 10% of annual revenue in the previous fiscal year.

Background: Why SAMR Issued Updated IP Antitrust Guidance Now

China’s antitrust regime for intellectual property has evolved rapidly since the 2008 Anti-Monopoly Law (反垄断法, fǎnlǒngduàn fǎ). The original 2019 IP Guidelines provided a basic framework, but SAMR determined they lacked specificity on three critical fronts: digital markets, standard-essential patent licensing, and the intersection of IP with data rights. The 2024 update closes these gaps while aligning with amendments to the Anti-Monopoly Law that took effect in August 2022, which introduced a “safe harbor” mechanism for low-market-share IP holders and increased maximum penalties for abuse of dominance.

Driving the revision is a surge in complaints from Chinese domestic companies — particularly in semiconductors, telecommunications, and electric vehicles — who argue that foreign patent holders impose unfair licensing terms. A SAMR white paper published in March 2024 noted that 67% of IP antitrust complaints received between 2021 and 2023 involved foreign SEP holders. The agency’s goal is to create a “level playing field” by providing clear red lines for IP conduct, while also encouraging voluntary compliance through the new indicators.

For foreign executives, the practical takeaway is straightforward: the days of relying on strong-form patent enforcement without antitrust risk in China are over. The guidance explicitly states that exercising IP rights “beyond the legitimate scope” can constitute abuse of dominance — a position that mirrors the approach taken in EU competition law but with Chinese procedural twists.

Five Key Provisions Foreign Companies Must Know

The 2024 guidance identifies five categories of conduct that SAMR will scrutinize most aggressively, each with specific behavioral prohibitions and safe harbor conditions.

1. Tying and Bundling of IP Licenses

SAMR now presumes that tying a desired patent license to an unwanted one — or requiring a licensee to purchase unrelated goods or services — is unlawful if the licensor holds market dominance. The guidance specifies three “red flag” scenarios: compulsory cross-licensing beyond reciprocity, mandatory grantback of improvements, and forced purchase of proprietary components. The recommended mitigation is offering separate license terms for each patent family, with written justification for any bundling.

2. Standard-Essential Patent (SEP) Licensing

SEP holders face the highest risk. The guidance requires that FRAND (fair, reasonable, and non-discriminatory) commitments be honored exactly as made to standard-setting organizations. SAMR will now examine four metrics: whether royalty rates are proportional to the value of the patented technology (not the product price), whether injunctions are sought in good faith before exhausting licensing negotiations, whether comparable license data is shared with implementers, and whether domestic Chinese licensees are offered terms no worse than foreign counterparts.

3. No-Challenge Clauses and Exclusivity Restrictions

Contractual clauses that prohibit a licensee from challenging the validity of a licensed patent are presumptively anticompetitive — a significant hardening from the 2019 guidance, which merely said such clauses “may” raise concerns. SAMR also warns against exclusivity provisions that prevent licensees from developing competing technologies, labeling them as potential vertical restraints. The exception is for licenses granted during settlement of patent litigation, where a reasonable no-challenge period (typically under 12 months) may be acceptable.

4. Discriminatory Licensing Across Domestic and Foreign Entities

A new compliance indicator explicitly states that “unjustified differences in royalty rates, territorial scope, or field-of-use restrictions between similarly situated licensees” will be treated as a prima facie violation. While this applies equally to all parties, SAMR’s enforcement history shows that foreign licensors are the primary targets — between 2020 and 2024, 80% of SAMR’s IP antitrust fines were levied against non-Chinese companies. Documentation of objective justifications for differential treatment (e.g., volume commitments, technical support scope) is now essential.

5. Abuse of Litigation and Administrative Enforcement

SAMR will now investigate the “strategic misuse” of patent enforcement, including filing baseless infringement lawsuits, seeking excessive damages, or requesting customs seizures without probable cause. The guidance borrows from the DOJ’s Walker Process standard in the U.S., but applies it more broadly to any enforcement action that “unreasonably excludes competitors from the market.” A penalty enhancement provision adds up to 50% to the base fine if SAMR determines that enforcement was used as a tool to suppress competition.

Enforcement Data: SAMR’s IP Antitrust Activity (2019-2024)

The table below summarizes SAMR’s public case data, drawn from agency announcements and annual competition reports. All figures are official or cross-referenced with credible legal journals.

Key takeaways from the data: IP-related cases now account for over one-fifth of all SAMR antitrust actions, up from 14% in 2019. The share of SEP-related cases within the IP category has grown from 25% in 2019 to 50% in 2024. Fines have more than tripled from ¥320 million to a projected ¥950 million, reflecting both larger penalties per case and a shift toward high-value technology sectors. Notably, 91% of all fines in IP cases came from foreign-invested enterprises or their subsidiaries — a data point that reinforces the compliance imperative for foreign rightsholders.

Practical Implications for Foreign Rightsholders

The 2024 guidance does not create new legal obligations — it clarifies how SAMR will apply existing provisions of the Anti-Monopoly Law to IP conduct. However, the specificity of the 23 compliance indicators effectively raises the bar for companies that previously operated with loose licensing frameworks. SAMR has indicated that it will conduct “spot-check audits” of licensing agreements for companies with over ¥100 million in annual China revenue, with priority given to SEP holders in 5G, video codecs, and automotive technologies.

For foreign executives managing China IP strategies, three operational changes are urgent:

• Revise standard license agreements to remove no-challenge clauses, broad grantback requirements, and any discriminatory tiers between Chinese and non-Chinese licensees.
• Build a FRAND compliance record for SEP holdings, including documented negotiation timelines, comparable license databases, and independent valuations of royalty rates relative to patent contribution.
• File a voluntary compliance report with SAMR if your company holds more than 20 SEP families in China — the agency has indicated that such filings will be treated favorably during investigations, potentially reducing fines by up to 30%.

The cost of non-compliance can be severe. In 2023, SAMR fined a Japanese electronics conglomerate ¥280 million for tying separate patent licenses — a penalty that represented 6.8% of its China segment revenue. The company also faced a 9-month suspension of its ability to enforce patents against Chinese competitors. For technology-driven foreign companies, such outcomes can destroy market position in China for years.

Enforcement Timeline: What to Expect

SAMR has publicly committed to a 5-year enforcement cycle for the IP guidance, with annual industry-specific deep dives (2025 focus: semiconductors and electric vehicle batteries; 2026 focus: pharmaceuticals and biotechnology). The agency is also deploying a new “Digital Market Enforcement Unit” within its Anti-Monopoly Bureau, staffed by 15 additional economists and 20 legal specialists. Foreign companies should anticipate more proactive investigations — not just responses to complaints — starting as early as Q1 2025.

NEXT STEPS

1. Conduct an IP antitrust compliance audit — Review your existing China licensing agreements, SEP licensing processes, and litigation strategy against SAMR’s 23 indicators. Use our Antitrust Compliance Checklist for Foreign IP Holders to identify high-risk clauses.
2. Prepare for SAMR engagement — If your company holds SEPs or licenses technology to Chinese partners, consider filing a voluntary compliance report. Read our guide on Responding to SAMR Antitrust Investigations for step-by-step protocols and documentation requirements.
3. Rebalance your China IP enforcement strategy — Shift away from aggressive litigation-based enforcement toward licensing negotiation and mediation. Our article on Best Practices for IP Licensing in China Under the 2024 Antitrust Rules provides model clause language and negotiation frameworks.

— China Gateway 360 —
Remote China market entry support, built around execution.